365 related articles for article (PubMed ID: 17391148)
21. Type 2 diabetes mellitus: a cardiovascular perspective.
Varughese GI; Tomson J; Lip GY
Int J Clin Pract; 2005 Jul; 59(7):798-816. PubMed ID: 15963208
[TBL] [Abstract][Full Text] [Related]
22. The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy.
Wyne KL
Diabetes Obes Metab; 2006 Jul; 8(4):365-80. PubMed ID: 16776743
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of hypertension in the cardiometabolic syndrome.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
[TBL] [Abstract][Full Text] [Related]
24. Metabolic complications of obesity: inflated or inflamed?
Chandalia M; Abate N
J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
[TBL] [Abstract][Full Text] [Related]
25. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
Correia ML; Rahmouni K
Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
[TBL] [Abstract][Full Text] [Related]
26. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.
Mavri A; Alessi MC; Juhan-Vague I
J Intern Med; 2004 Apr; 255(4):448-56. PubMed ID: 15049879
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.
Zarich SW
Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015
[TBL] [Abstract][Full Text] [Related]
29. The metabolic syndrome, diabetes and lung dysfunction.
Tiengo A; Fadini GP; Avogaro A
Diabetes Metab; 2008 Nov; 34(5):447-54. PubMed ID: 18829364
[TBL] [Abstract][Full Text] [Related]
30. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care.
Lender D; Sysko SK
Pharmacotherapy; 2006 May; 26(5 Pt 2):3S-12S. PubMed ID: 16637782
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome: diabetes and cardiovascular disease.
Gupta S; Gupta BM
Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
[TBL] [Abstract][Full Text] [Related]
32. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
33. PPAR agonists and the metabolic syndrome.
Staels B
Therapie; 2007; 62(4):319-26. PubMed ID: 17983557
[TBL] [Abstract][Full Text] [Related]
34. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases.
Szczepanska-Sadowska E; Cudnoch-Jedrzejewska A; Ufnal M; Zera T
J Physiol Pharmacol; 2010 Oct; 61(5):509-21. PubMed ID: 21081794
[TBL] [Abstract][Full Text] [Related]
35. Diabetes and cardiovascular disease: related disorders created by disturbances in the endogenous clock.
Scott EM; Carter AM; Grant PJ
J Indian Med Assoc; 2008 Nov; 106(11):736-8, 740. PubMed ID: 19368099
[TBL] [Abstract][Full Text] [Related]
36. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
Ren J; Kelley RO
Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
[TBL] [Abstract][Full Text] [Related]
37. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
Guri AJ; Hontecillas R; Bassaganya-Riera J
J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
[TBL] [Abstract][Full Text] [Related]
38. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
Nathan BM; Moran A
Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
[TBL] [Abstract][Full Text] [Related]
39. Hypertension as part of the metabolic syndrome.
Cheung B
J Hum Hypertens; 2008 Dec; 22(12):871-4. PubMed ID: 18548089
[TBL] [Abstract][Full Text] [Related]
40. New therapeutic options for the metabolic syndrome: what's next?
Flordellis CS; Ilias I; Papavassiliou AG
Trends Endocrinol Metab; 2005 Aug; 16(6):254-60. PubMed ID: 16002303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
